Abstract
The focus of this TriMark Publications report is to describe the specific
segment of the life sciences market called DNA sequencing. This analysis
includes all of the generally-accepted DNA-oriented analytical activities that
are currently used today, such as enabling technologies like polymerase chain
reaction (PCR). It examines these measurement technology platforms and their
reagents and supplies as utilized in biotechnology research, pharmacology and
healthcare. Generally, diagnostic tests which are marketed primarily as
over-the-counter products directly to patients are not included in this study,
although there is inevitably some overlap. This examination will: 1) identify
viable technology drivers through a comprehensive look at various platform
technologies for molecular sequencing, including immunoassays electrophoretic
methods, probe-based nucleic acid assays, microarrays and non-PCR sequencing;
2) obtain a complete understanding of the chief molecular sequencing tests for
predictive, screening, prognostic, monitoring, pharmacogenomic and theranostic
applications; 3) discover feasible market opportunities via an identification
of high-growth applications in different therapeutic areas, with a focus on
the biggest and expanding markets-communicable diseases, cardiology and
oncology; and 4) focus on global industry development through an in-depth
analysis of the major world markets for molecular sequencing, including
forecasts for growth.
| 
View Cart
